AzTrials
AzTrials

HerniaBigWigNCT02525666

Bilateral Laparoscopic Repair of Groin Hernias With One Large Self-fixating Mesh (ProGripTM)

An observational study of Hernia and Recurrence, run by Algemeen Ziekenhuis Maria Middelares at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Investigation of a bilateral inguinal hernia repair using one large self-fixating mesh covering both groins. Health outcomes are assessed using different questionaires with focus on urinary symptoms (with ICIQ-MLUTS score), the recurrence rate, postoperative pain measurement, and Quality of Life assessment with… Read more about this study

Who is it for?
Ages 18 to 80 years, men only
Conditions the study is for
Hernia, Recurrence, Quality of Life
How many people
100 participants
Where
1 siteBelgium
Study dates
Aug 2015to 28 Jun 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: 100 adult patients, men only, ages between 18 and 80 years with a primary bilateral inguinal hernias will be included based on clinical examination and/or ultrasonography.

Who may be able to join

  • patients scheduled for primary bilateral inguinal hernia repair

Who cannot join

  • recurrent groin hernia
  • open hernia repair
  • unilateral hernias
  • concomitant repair of another abdominal hernia e.g. umbilical hernia
  • hernia repair combined with another surgical procedure
  • emergency operations, like incarcerated hernias
Show all 10Show fewer
  • patients under the age of 18 years or over 80 years
  • ASA score 4 or more
  • patients unable to perform the QoL assessment, because of language barrier or intellectual incapacity
  • no informed consent of the patient

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • AZ Maria Middelares

    Ghent, 9000

Other trials in Belgium

About this study

Official title: Evaluation of Bilateral Laparoscopic Repair of Groin Hernias With One Large Self-fixating Mesh (ProGripTM) in a Prospective Cohort Study

Investigation of a bilateral inguinal hernia repair using one large self-fixating mesh covering both groins. Health outcomes are assessed using different questionaires with focus on urinary symptoms (with ICIQ-MLUTS score), the recurrence rate, postoperative pain measurement, and Quality of Life assessment with EuraHS-QoL and chronic pain monitoring for 12 months.

Read the detailed description
  1. INTRODUCTION Evidence in groin hernia repair showed a significant reduction in recurrence rates since the introduction of mesh repair. Hence all current guidelines state that in surgical treatment of groin hernias in adults a mesh should be used. In laparoscopic groin hernia repair a mesh is positioned in the preperitoneal plane. Two techniques are commonly used. A transabdominal technique (TransAbdominal PrePeritoneal - TAPP), in which the preperitoneal plane is dissected throughout the abdomen, with a closure of the peritoneum after positioning of the mesh, and a preperitoneal technique (Totally ExtraPeritoneal - TEP) in which the peritoneum remains intact. Fixation of the mesh was originally performed by penetrating fixation, using staples or tackers. Alternative fixation with glue, self-fixating meshes or no mesh fixation at all, have been proposed to avoid the postoperative pain related to the penetrating fixation. Several studies were not able to show significant differences in recurrence rates between the different mesh fixation techniques. In general, sufficient overlap seems more important than fixation of the mesh. However, current guidelines state that tacker or suture fixation of the mesh for groin hernia should be avoided. Concerns are often raised about large medial hernias (EHS classification: M3) because the medial overlap of the mesh beyond the hernia defect is small. An overlap of less than 2-3 cm may lead to protrusion of the mesh in the hernia opening, and this risk is increased in large direct hernias. In general, the larger the hernia opening, the more overlapping there should be. Observational studies have shown a higher recurrence rate in the repair of direct (i.e. medial) hernias. In a recent consensus statement, Poelman et al. stated that diverse types of inguinal hernias (direct vs. indirect, large vs. small) should be distinguished and treated in a different way. Despite the fact that randomized trials did not differentiate between large or small hernias, they state that the use of a heavy weight mesh, mesh fixation or larger mesh size should be considered in case of large medial hernias. In repair of bilateral inguinal hernias, current guidelines state that laparoscopic treatment is the preferable approach, without clear advantage of TEP over TAPP or vice-versa. During transabdominal (TAPP) repair, evaluation and subsequent treatment of a contralateral hernia can be performed without additional incision and/or trocar placement. Whether one large mesh or two separate meshes with sufficient overlap should be used, remains unclear. The IEHS guidelines state that both options can be used. However, the recurrences detected after the use of two separate meshes suggest the presence of weaker zone at the midline, despite the overlap. On the other hand, application of one large mesh seems to be technically more difficult. In laparoscopic groin hernia repair, the mesh is placed in the anatomical space between pubic bone and bladder. Any type of mesh might therefore potentially influence the urinary bladder function. Until now it is not clear if these urinary symptoms will be different in patients with one large mesh compared to those with two overlapping meshes.
  2. AIM AND DESIGN OF THE STUDY Purpose of this study is the assessment urinary symptoms after bilateral repair using one large self-fixating mesh covering both groins in repair of bilateral inguinal hernias. Health outcomes are assessed using different questionaires with focus on urinary symptoms (with ICIQ-MLUTS score), the recurrence rate, postoperative pain measurement, and Quality of Life assessment with EuraHS-QoL and chronic pain monitoring for 12 months. A total of 100 male patients will be entered in the trial in AZ MARIA MIDDELARES, for which an inclusion period of 24 months is anticipated. Study inclusion will be based on clinical examination and/or ultrasonography. Informed Consent will be obtained pre-operatively.
  3. OPERATIVE STANDARD PROCEDURES A bilateral laparoscopic groin hernia repair will be performed, using one large self-fixating mesh (ProGripTM). in transabdominal (TAPP) approach or in totally extra-peritoneal (TEP) approach on all patients.
  4. FOLLOW-UP After receiving informed consent and planned surgery, patients will get invited for a standard clinical check-up (at 1 month en 12 months post-operatively) and for assessment of urinary symptoms using the ICIQ-MLUTS (International Consultation on Incontinence modular Questionnaire on Lower Urinary Tract Symptoms) at 1 month, 3 months en 12 months post-operatively. Recurrence rates will be based on clinical examination by the surgeon during follow-up. In case of uncertainty during clinical evaluation further investigation using ultrasonography and/or CT scan will be performed. Quality of Life, using the pre- and postoperative EuraHS-QoL score and postoperative pain using a VAS (Visual Analogue Scale) scale will be assessed during the clinical follow-up moments. Additional registration of pain medication used will be performed.
  5. DATA COLLECTION AND ANALYSIS All data related to the surgical procedure, patient comorbidities and the post-operative course will be documented prospectively. Anonymized data of all patients will be collected in the online platform EuraHS (European Registry of Abdominal Wall Hernias), developed by the scientific working of European Hernia Society EHS under a specific study account.

A study specific CRF including the ICIQ-MLUTS, the EuraHS-QoL, the VAS (visual analog scale) and VRS (verbal rating scale will be provided by the trial secretariat and gathered by the study coordinator.

Medical subject headings
Hernia, Recurrence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of ICIQ-MLUTS Score

    Assessment of urinary symptoms with the ICIQ_MLUTS score at 12 month after laparoscopic repair of bilateral inguinal hernia

    Measured: 12 months

Secondary outcomes (2)
  1. Assessment of ICIQ-MLUTS Score

    Assessment of urinary symptoms with the ICIQ_MLUTS score (pre-operatively, 1 and 3 month postoperatively)

    Measured: preoperative, 1 month and 3 month post-operative

  2. Quality of Life assessment

    Quality of Life assessment with the EuraHS QoL score (pre-operatively, 1, 3 and 12 month postoperatively)

    Measured: pre-operatively, 1, 3 and 12 month postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2015 (estimated)
  2. Study startAug 2015
  3. Primary completion28 Jun 2018
  4. Study completion28 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02525666
Sponsor's protocol ID
BigWig Study
Acronym
BigWig
Status last verified
Jul 2018
First submitted
5 Aug 2015
Last updated
16 Jul 2018
Results posted
No
Data monitoring committee
No

Publications

  • Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, de Lange D, Fortelny R, Heikkinen T, Kingsnorth A, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Miserez M. European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia. 2009 Aug;13(4):343-403. doi: 10.1007/s10029-009-0529-7. Epub 2009 Jul 28.

    PubMed 19636493
  • Poelman MM, van den Heuvel B, Deelder JD, Abis GS, Beudeker N, Bittner RR, Campanelli G, van Dam D, Dwars BJ, Eker HH, Fingerhut A, Khatkov I, Koeckerling F, Kukleta JF, Miserez M, Montgomery A, Munoz Brands RM, Morales Conde S, Muysoms FE, Soltes M, Tromp W, Yavuz Y, Bonjer HJ. EAES Consensus Development Conference on endoscopic repair of groin hernias. Surg Endosc. 2013 Oct;27(10):3505-19. doi: 10.1007/s00464-013-3001-9. Epub 2013 May 25. No abstract available.

    PubMed 23708718
  • Tam KW, Liang HH, Chai CY. Outcomes of staple fixation of mesh versus nonfixation in laparoscopic total extraperitoneal inguinal repair: a meta-analysis of randomized controlled trials. World J Surg. 2010 Dec;34(12):3065-74. doi: 10.1007/s00268-010-0760-5.

    PubMed 20714896
  • Donovan JL, Peters TJ, Abrams P, Brookes ST, de aa Rosette JJ, Schafer W. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol. 2000 Dec;164(6):1948-55.

    PubMed 11061889
  • Muysoms F, Dewulf M, Kyle-Leinhase I, Baumgartner R, Ameye F, Defoort B, Pletinckx P. Laparoscopic bilateral groin hernia repair with one large self-fixating mesh: prospective observational study with patient-reported outcome of urological symptoms and EuraHS-QoL scores. Surg Endosc. 2020 Feb;34(2):920-929. doi: 10.1007/s00464-019-06850-7. Epub 2019 May 28.

    PubMed 31139996

Questions about this trial

What is this clinical trial studying?

An observational study of Hernia and Recurrence, run by Algemeen Ziekenhuis Maria Middelares at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of ICIQ-MLUTS Score (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02525666, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2018; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in